BELLEROPHON THERAPEUTICS

Bellerophon Therapeutics LLC is a clinical stage biotherapeutics company focused on developing innovative therapies at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary and cardiac diseases. Two of the company's product candidates are based on its proprietary pulsatile nitric oxide delivery device, INOpulse®, and are in Phase 2 clinical trials – one for the treatment of PAH and a second for the treatment of PH-COPD. The comp... any's third product candidate, bioabsorbable cardiac matrix (BCM), is an injectable device currently undergoing a feasibility clinical trial, which is a CE mark registration trial in the European Union and is comparable to a Phase 2 trial in U.S. drug development, for the prevention of cardiac remodeling and subsequent congestive heart failure following acute myocardial infarction (heart attack).

#SimilarOrganizations #People #Financial #Website #More

BELLEROPHON THERAPEUTICS

Social Links:

Linkedin

Industry:

Biotechnology Health Care Medical

Founded:

2009-01-01

Address:

Warren, New Jersey, United States

Country:

United States

Website Url:

http://www.bellerophon.com

Total Employee:

11+

Status:

Active

Total Funding:

149 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Font Awesome

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

Current Advisors List

jonathan-peacock_image

Jonathan Peacock Chairman @ Bellerophon Therapeutics
Board_member
2014-06-01

Current Employees Featured

fabian-tenenbaum_image

Fabian Tenenbaum
Fabian Tenenbaum Chief Executive Officer @ Bellerophon Therapeutics
Chief Executive Officer
2016-11-01

peter-fernandes_image

Peter Fernandes
Peter Fernandes Chief Regulatory and Safety Officer @ Bellerophon Therapeutics
Chief Regulatory and Safety Officer
2012-10-01

hunter-gillies_image

Hunter Gillies
Hunter Gillies Acting CMO @ Bellerophon Therapeutics
Acting CMO
2018-11-01

Stock Details

Company's stock symbol is NASDAQ:BLPH

Investors List

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series A - Bellerophon Therapeutics

new-mountain-capital_image

New Mountain Capital

New Mountain Capital investment in Series A - Bellerophon Therapeutics

aravis-ventures_image

Aravis Ventures

Aravis Ventures investment in Series A - Bellerophon Therapeutics

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series A - Bellerophon Therapeutics

venrock_image

Venrock

Venrock investment in Series A - Bellerophon Therapeutics

Official Site Inspections

http://www.bellerophon.com Semrush global rank: 9.55 M Semrush visits lastest month: 141

Host Informations
Whois Informations

Loading ...

More informations about "Bellerophon Therapeutics" on Search Engine